drugset / Trial / NCT06620042
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
NaSingle-groupOpen-labelOther
Summary
This is a prospective open-label observational study of patients with treatment resistant bipolar depression referred for intravenous ketamine, with an interventional component of fMRI.
Timeline
- Start
- 2024-11-12
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | — | Intravenous |